Sponsored by Blue Mountain. Researched and published by Axendia.
Artificial Intelligence is rapidly reshaping the life sciences industry, but where are organizations actually investing? Which use cases are delivering value today? And what challenges are slowing adoption?
To help answer these questions, Blue Mountain partnered with Axendia to conduct a comprehensive market research study of 194 life sciences professionals and technology leaders. The resulting report provides a data-driven view of how organizations are approaching Generative AI, Agentic AI, and Autonomous AI across quality, manufacturing, validation, regulatory affairs, and operations.
Download this report to learn:
- Where life sciences organizations are investing in AI
- The most impactful AI use cases across the product lifecycle
- Key barriers to adoption, including data readiness and governance
- How companies are measuring AI success
- When Generative, Agentic, and Autonomous AI are expected to become mainstream
- What separates AI innovators from organizations still in the pilot phase
Whether you’re responsible for digital transformation, quality, manufacturing, validation, or IT strategy, this research provides valuable insight into the opportunities and realities of AI adoption in regulated environments.
Download the report and discover what the life sciences industry is really saying about AI.